{"transactions":[{"id":866725,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63271,"kind":"person","name":"BEDU-ADDO FRANK","position":1,"cik":"0001770756","reported_name":"BEDU-ADDO FRANK","relationship":{"director":true,"officer":true,"officer_title":"President/CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-03-03T23:47:33.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":548782,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on January 12, 2027, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":548782,"derivative":{"exercise_price":0.98,"expiration_date":"2036-01-12","underlying":"Common Stock","underlying_shares":548782},"source":{"system":"sec-edgar","filing":"0001140361-26-007649","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036126007649/form4.xml","form_type":"4"}},{"id":866723,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63270,"kind":"person","name":"CONN GREGORY","position":1,"cik":"0001770008","reported_name":"CONN GREGORY","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-03-03T23:47:32.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on January 12, 2027, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":150000,"derivative":{"exercise_price":0.98,"expiration_date":"2036-01-12","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001140361-26-007648","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036126007648/form4.xml","form_type":"4"}},{"id":866722,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63269,"kind":"person","name":"Boesgaard Lars","position":1,"cik":"0001403893","reported_name":"Boesgaard Lars","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-03-03T23:47:29.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on January 12, 2027, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":300000,"derivative":{"exercise_price":0.98,"expiration_date":"2036-01-12","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001140361-26-007646","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036126007646/form4.xml","form_type":"4"}},{"id":866721,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63268,"kind":"person","name":"Toutain Stephan","position":1,"cik":"0001681658","reported_name":"Toutain Stephan","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-03-03T23:47:27.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on January 12, 2027, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":300000,"derivative":{"exercise_price":0.98,"expiration_date":"2036-01-12","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001140361-26-007644","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036126007644/form4.xml","form_type":"4"}},{"id":867112,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":35786,"kind":"person","name":"Ali-Jackson Kamil","position":1,"cik":"0001654337","reported_name":"Ali-Jackson Kamil","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-03-03T23:47:23.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":54876,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date."}],"balance_after":54876,"derivative":{"exercise_price":0.98,"expiration_date":"2036-01-12","underlying":"Common Stock","underlying_shares":54876},"source":{"system":"sec-edgar","filing":"0001140361-26-007641","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654337/000114036126007641/form4.xml","form_type":"4"}},{"id":866720,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":38773,"kind":"person","name":"BRAWLEY OTIS W","position":1,"cik":"0001213029","reported_name":"BRAWLEY OTIS W","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-03-03T23:47:22.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":54876,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date."}],"balance_after":54876,"derivative":{"exercise_price":0.98,"expiration_date":"2036-01-12","underlying":"Common Stock","underlying_shares":54876},"source":{"system":"sec-edgar","filing":"0001140361-26-007640","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036126007640/form4.xml","form_type":"4"}},{"id":866719,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":41889,"kind":"person","name":"Glover Stephen C.","position":1,"cik":"0001304406","reported_name":"Glover Stephen C.","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-03-03T23:47:21.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":54876,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date."}],"balance_after":54876,"derivative":{"exercise_price":0.98,"expiration_date":"2036-01-12","underlying":"Common Stock","underlying_shares":54876},"source":{"system":"sec-edgar","filing":"0001140361-26-007639","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036126007639/form4.xml","form_type":"4"}},{"id":868576,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63409,"kind":"person","name":"Shepard Kirk V.","position":1,"cik":"0002009007","reported_name":"Shepard Kirk V.","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-03-03T18:47:30.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on January 12, 2027, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":300000,"derivative":{"exercise_price":0.98,"expiration_date":"2036-01-12","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001140361-26-007647","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2009007/000114036126007647/form4.xml","form_type":"4"}},{"id":868345,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63388,"kind":"person","name":"Brown Spencer D.","position":1,"cik":"0001930908","reported_name":"Brown Spencer D.","relationship":{"officer":true,"officer_title":"Senior VP, General Counsel"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-03-03T18:47:28.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on January 12, 2027, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":300000,"derivative":{"exercise_price":0.98,"expiration_date":"2036-01-12","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001140361-26-007645","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1930908/000114036126007645/form4.xml","form_type":"4"}},{"id":866975,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-03-03T18:47:26.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":54876,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date."}],"balance_after":54876,"derivative":{"exercise_price":0.98,"expiration_date":"2036-01-12","underlying":"Common Stock","underlying_shares":54876},"source":{"system":"sec-edgar","filing":"0001140361-26-007643","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492710/000114036126007643/form4.xml","form_type":"4"}},{"id":867880,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63352,"kind":"person","name":"Iliev Ilian","position":1,"cik":"0001808804","reported_name":"Iliev Ilian","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-03-03T18:47:24.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":54876,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date."}],"balance_after":54876,"derivative":{"exercise_price":0.98,"expiration_date":"2036-01-12","underlying":"Common Stock","underlying_shares":54876},"source":{"system":"sec-edgar","filing":"0001140361-26-007642","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808804/000114036126007642/form4.xml","form_type":"4"}},{"id":1081378,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63271,"kind":"person","name":"BEDU-ADDO FRANK","position":1,"cik":"0001770756","reported_name":"BEDU-ADDO FRANK","relationship":{"director":true,"officer":true,"officer_title":"President/CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-07-25T22:12:55.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on June 12, 2026, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":150000,"derivative":{"exercise_price":1.79,"expiration_date":"2035-06-12","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001140361-25-027405","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036125027405/form4.xml","form_type":"4"}},{"id":1081377,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63271,"kind":"person","name":"BEDU-ADDO FRANK","position":1,"cik":"0001770756","reported_name":"BEDU-ADDO FRANK","relationship":{"director":true,"officer":true,"officer_title":"President/CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-07-25T22:12:55.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on February 28,2025, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":300000,"derivative":{"exercise_price":5.87,"expiration_date":"2034-02-28","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001140361-25-027405","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036125027405/form4.xml","form_type":"4"}},{"id":1081376,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63269,"kind":"person","name":"Boesgaard Lars","position":1,"cik":"0001403893","reported_name":"Boesgaard Lars","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-07-25T22:12:51.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on June 12, 2026, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":150000,"derivative":{"exercise_price":1.79,"expiration_date":"2035-06-12","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001140361-25-027402","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036125027402/form4.xml","form_type":"4"}},{"id":1081375,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63270,"kind":"person","name":"CONN GREGORY","position":1,"cik":"0001770008","reported_name":"CONN GREGORY","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-07-25T22:12:49.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on June 12, 2026, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":40000,"derivative":{"exercise_price":1.79,"expiration_date":"2035-06-12","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001140361-25-027401","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036125027401/form4.xml","form_type":"4"}},{"id":1081374,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63270,"kind":"person","name":"CONN GREGORY","position":1,"cik":"0001770008","reported_name":"CONN GREGORY","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-07-25T22:12:49.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":46648,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on February 28, 2025, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":46648,"derivative":{"exercise_price":5.87,"expiration_date":"2034-02-28","underlying":"Common Stock","underlying_shares":46648},"source":{"system":"sec-edgar","filing":"0001140361-25-027401","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036125027401/form4.xml","form_type":"4"}},{"id":1081373,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63268,"kind":"person","name":"Toutain Stephan","position":1,"cik":"0001681658","reported_name":"Toutain Stephan","relationship":{"officer":true,"officer_title":"Chief Operations Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-07-25T22:12:47.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on June 12, 2026, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":150000,"derivative":{"exercise_price":1.79,"expiration_date":"2035-06-12","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001140361-25-027400","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036125027400/form4.xml","form_type":"4"}},{"id":1081487,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63409,"kind":"person","name":"Shepard Kirk V.","position":1,"cik":"0002009007","reported_name":"Shepard Kirk V.","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-07-25T18:12:54.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on June 12, 2026, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":150000,"derivative":{"exercise_price":1.79,"expiration_date":"2035-06-12","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001140361-25-027404","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2009007/000114036125027404/form4.xml","form_type":"4"}},{"id":1081475,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63388,"kind":"person","name":"Brown Spencer D.","position":1,"cik":"0001930908","reported_name":"Brown Spencer D.","relationship":{"officer":true,"officer_title":"Senior VP, General Counsel"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-07-25T18:12:52.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on June 12, 2026, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":150000,"derivative":{"exercise_price":1.79,"expiration_date":"2035-06-12","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001140361-25-027403","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1930908/000114036125027403/form4.xml","form_type":"4"}},{"id":1081474,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63388,"kind":"person","name":"Brown Spencer D.","position":1,"cik":"0001930908","reported_name":"Brown Spencer D.","relationship":{"officer":true,"officer_title":"Senior VP, General Counsel"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-07-25T18:12:52.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":56000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on February 28,2025, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":56000,"derivative":{"exercise_price":5.87,"expiration_date":"2034-02-28","underlying":"Common Stock","underlying_shares":56000},"source":{"system":"sec-edgar","filing":"0001140361-25-027403","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1930908/000114036125027403/form4.xml","form_type":"4"}},{"id":1114855,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":38773,"kind":"person","name":"BRAWLEY OTIS W","position":1,"cik":"0001213029","reported_name":"BRAWLEY OTIS W","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-06-11T22:00:37.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":22700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date."}],"balance_after":22700,"derivative":{"exercise_price":1.75,"expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":22700},"source":{"system":"sec-edgar","filing":"0001140361-25-022227","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036125022227/form4.xml","form_type":"4"}},{"id":1114907,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":35786,"kind":"person","name":"Ali-Jackson Kamil","position":1,"cik":"0001654337","reported_name":"Ali-Jackson Kamil","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-06-11T22:00:36.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":22700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date."}],"balance_after":22700,"derivative":{"exercise_price":1.75,"expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":22700},"source":{"system":"sec-edgar","filing":"0001140361-25-022225","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654337/000114036125022225/form4.xml","form_type":"4"}},{"id":1114854,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":41889,"kind":"person","name":"Glover Stephen C.","position":1,"cik":"0001304406","reported_name":"Glover Stephen C.","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-06-11T22:00:33.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":22700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date."}],"balance_after":22700,"derivative":{"exercise_price":1.75,"expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":22700},"source":{"system":"sec-edgar","filing":"0001140361-25-022223","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036125022223/form4.xml","form_type":"4"}},{"id":1115092,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63352,"kind":"person","name":"Iliev Ilian","position":1,"cik":"0001808804","reported_name":"Iliev Ilian","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-06-11T18:00:35.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":22700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date."}],"balance_after":22700,"derivative":{"exercise_price":1.75,"expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":22700},"source":{"system":"sec-edgar","filing":"0001140361-25-022226","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808804/000114036125022226/form4.xml","form_type":"4"}},{"id":1114875,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-06-11T18:00:35.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":22700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date."}],"balance_after":22700,"derivative":{"exercise_price":1.75,"expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":22700},"source":{"system":"sec-edgar","filing":"0001140361-25-022224","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492710/000114036125022224/form4.xml","form_type":"4"}},{"id":1235650,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":41889,"kind":"person","name":"Glover Stephen C.","position":1,"cik":"0001304406","reported_name":"Glover Stephen C.","relationship":{"director":true}}],"security":"Common Warrant","published_at":"2025-03-03T21:45:20.000Z","date":"2025-02-28","kind":"purchase","planned":false,"acquired":true,"shares":15061,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchase price for the Common Warrant is included in the purchase price for the shares of Common Stock reflected in Table I above."}],"balance_after":15061,"derivative":{"exercise_price":1.53,"exercise_date":"2025-02-28","expiration_date":"2030-02-28","underlying":"Common Stock","underlying_shares":15061},"source":{"system":"sec-edgar","filing":"0001140361-25-006783","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036125006783/form4.xml","form_type":"4"}},{"id":1235649,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":41889,"kind":"person","name":"Glover Stephen C.","position":1,"cik":"0001304406","reported_name":"Glover Stephen C.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-03-03T21:45:20.000Z","date":"2025-02-28","kind":"purchase","planned":false,"acquired":true,"shares":15061,"price":1.66,"value":25001.26,"ownership":{"direct":true},"balance_after":78851,"source":{"system":"sec-edgar","filing":"0001140361-25-006783","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036125006783/form4.xml","form_type":"4"}},{"id":1235700,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true}}],"security":"Common Warrant","published_at":"2025-03-03T16:45:42.000Z","date":"2025-02-28","kind":"purchase","planned":false,"acquired":true,"shares":15060,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchase price for the Common Warrant is included in the purchase price for the shares of Common Stock reflected in Table I above."}],"balance_after":15060,"derivative":{"exercise_price":1.53,"exercise_date":"2025-02-28","expiration_date":"2030-02-28","underlying":"Common Stock","underlying_shares":15060},"source":{"system":"sec-edgar","filing":"0001140361-25-006784","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492710/000114036125006784/form4.xml","form_type":"4"}},{"id":1235699,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-03-03T16:45:42.000Z","date":"2025-02-28","kind":"purchase","planned":false,"acquired":true,"shares":15060,"price":1.66,"value":24999.6,"ownership":{"direct":true},"balance_after":61213,"source":{"system":"sec-edgar","filing":"0001140361-25-006784","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492710/000114036125006784/form4.xml","form_type":"4"}},{"id":1469465,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":41889,"kind":"person","name":"Glover Stephen C.","position":1,"cik":"0001304406","reported_name":"Glover Stephen C.","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-06-25T20:05:11.000Z","date":"2024-06-24","kind":"grant","planned":false,"acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date."}],"balance_after":9000,"derivative":{"exercise_price":2.86,"expiration_date":"2034-06-24","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001140361-24-031293","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036124031293/form4.xml","form_type":"4"}},{"id":1469464,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":89556,"kind":"person","name":"SYKES RICHARD","position":1,"cik":"0001372810","reported_name":"SYKES RICHARD","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-06-25T20:05:10.000Z","date":"2024-06-24","kind":"grant","planned":false,"acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date."}],"balance_after":9000,"derivative":{"exercise_price":2.86,"expiration_date":"2034-06-24","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001140361-24-031292","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036124031292/form4.xml","form_type":"4"}},{"id":1469463,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":38773,"kind":"person","name":"BRAWLEY OTIS W","position":1,"cik":"0001213029","reported_name":"BRAWLEY OTIS W","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-06-25T20:05:07.000Z","date":"2024-06-24","kind":"grant","planned":false,"acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date."}],"balance_after":9000,"derivative":{"exercise_price":2.86,"expiration_date":"2034-06-24","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001140361-24-031290","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036124031290/form4.xml","form_type":"4"}},{"id":1469500,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":35786,"kind":"person","name":"Ali-Jackson Kamil","position":1,"cik":"0001654337","reported_name":"Ali-Jackson Kamil","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-06-25T20:05:06.000Z","date":"2024-06-24","kind":"grant","planned":false,"acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date."}],"balance_after":9000,"derivative":{"exercise_price":2.86,"expiration_date":"2034-06-24","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001140361-24-031289","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654337/000114036124031289/form4.xml","form_type":"4"}},{"id":1469469,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-06-25T16:05:13.000Z","date":"2024-06-24","kind":"grant","planned":false,"acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date."}],"balance_after":9000,"derivative":{"exercise_price":2.86,"expiration_date":"2034-06-24","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001140361-24-031294","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492710/000114036124031294/form4.xml","form_type":"4"}},{"id":1469585,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63352,"kind":"person","name":"Iliev Ilian","position":1,"cik":"0001808804","reported_name":"Iliev Ilian","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-06-25T16:05:08.000Z","date":"2024-06-24","kind":"grant","planned":false,"acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date."}],"balance_after":9000,"derivative":{"exercise_price":2.86,"expiration_date":"2034-06-24","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001140361-24-031291","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808804/000114036124031291/form4.xml","form_type":"4"}},{"id":1530495,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63268,"kind":"person","name":"Toutain Stephan","position":1,"cik":"0001681658","reported_name":"Toutain Stephan","relationship":{"officer":true,"officer_title":"Chief Operations Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-05-02T20:17:34.000Z","date":"2024-05-01","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted by the Issuer as an inducement material to the Reporting Person entering into employment with the Issuer in accordance with Nasdaq Rule 5635(c)(4) and the Issuer's 2019 Inducement Plan, as amended. The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on May 1, 2025, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":200000,"derivative":{"exercise_price":3.61,"expiration_date":"2034-05-01","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001140361-24-024002","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036124024002/form4.xml","form_type":"4"}},{"id":1673283,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63409,"kind":"person","name":"Shepard Kirk V.","position":1,"cik":"0002009007","reported_name":"Shepard Kirk V.","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-01-23T16:33:38.000Z","date":"2024-01-22","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted by the Issuer as an inducement material to the Reporting Person entering into employment with the Issuer in accordance with Nasdaq Rule 5635(c)(4) and the Issuer's 2019 Inducement Plan, as amended. The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on January 22,2025, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":200000,"derivative":{"exercise_price":4.49,"expiration_date":"2034-01-22","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001140361-24-003434","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2009007/000114036124003434/form4.xml","form_type":"4"}},{"id":1723748,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63269,"kind":"person","name":"Boesgaard Lars","position":1,"cik":"0001403893","reported_name":"Boesgaard Lars","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-12-04T23:14:58.000Z","date":"2023-12-04","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted by the Issuer as an inducement material to the Reporting Person entering into employment with the Issuer in accordance with Nasdaq Rule 5635(c)(4) and the Issuer's 2019 Inducement Plan, as amended. The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on December 4, 2024, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":200000,"derivative":{"exercise_price":5.28,"expiration_date":"2033-12-04","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001140361-23-056240","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036123056240/form4.xml","form_type":"4"}},{"id":1828606,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":38773,"kind":"person","name":"BRAWLEY OTIS W","position":1,"cik":"0001213029","reported_name":"BRAWLEY OTIS W","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-07-17T21:29:17.000Z","date":"2023-07-14","kind":"grant","planned":false,"acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date."}],"balance_after":9000,"derivative":{"exercise_price":5.13,"expiration_date":"2033-07-14","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001140361-23-034838","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036123034838/form4.xml","form_type":"4"}},{"id":1828637,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":35786,"kind":"person","name":"Ali-Jackson Kamil","position":1,"cik":"0001654337","reported_name":"Ali-Jackson Kamil","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-07-17T21:28:21.000Z","date":"2023-07-14","kind":"grant","planned":false,"acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date."}],"balance_after":9000,"derivative":{"exercise_price":5.13,"expiration_date":"2033-07-14","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001140361-23-034836","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654337/000114036123034836/form4.xml","form_type":"4"}},{"id":1828605,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":89556,"kind":"person","name":"SYKES RICHARD","position":1,"cik":"0001372810","reported_name":"SYKES RICHARD","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-07-17T21:27:25.000Z","date":"2023-07-14","kind":"grant","planned":false,"acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date."}],"balance_after":9000,"derivative":{"exercise_price":5.13,"expiration_date":"2033-07-14","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001140361-23-034832","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036123034832/form4.xml","form_type":"4"}},{"id":1828604,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":41889,"kind":"person","name":"Glover Stephen C.","position":1,"cik":"0001304406","reported_name":"Glover Stephen C.","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-07-17T21:26:34.000Z","date":"2023-07-14","kind":"grant","planned":false,"acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date."}],"balance_after":9000,"derivative":{"exercise_price":5.13,"expiration_date":"2033-07-14","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001140361-23-034831","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036123034831/form4.xml","form_type":"4"}},{"id":1828625,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-07-17T17:30:12.000Z","date":"2023-07-14","kind":"grant","planned":false,"acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date."}],"balance_after":9000,"derivative":{"exercise_price":5.13,"expiration_date":"2033-07-14","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001140361-23-034839","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492710/000114036123034839/form4.xml","form_type":"4"}},{"id":1828764,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63352,"kind":"person","name":"Iliev Ilian","position":1,"cik":"0001808804","reported_name":"Iliev Ilian","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-07-17T17:25:38.000Z","date":"2023-07-14","kind":"grant","planned":false,"acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date."}],"balance_after":9000,"derivative":{"exercise_price":5.13,"expiration_date":"2033-07-14","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001140361-23-034829","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808804/000114036123034829/form4.xml","form_type":"4"}},{"id":2060308,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":38435,"kind":"person","name":"HILL MATTHEW C","position":1,"cik":"0001278675","reported_name":"HILL MATTHEW C","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-01-06T21:59:18.000Z","date":"2023-01-05","kind":"grant","acquired":true,"shares":161200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, representing a right to purchase a total of 161,200 shares of Common Stock, will become exercisable on January 5, 2024, with 25% vesting on that date and the remaining 75% vesting in equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date, until fully vested on January 5, 2027."}],"balance_after":161200,"derivative":{"exercise_price":11.61,"expiration_date":"2033-01-05","underlying":"Common Stock","underlying_shares":161200},"source":{"system":"sec-edgar","filing":"0001140361-23-000826","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036123000826/form4.xml","form_type":"4"}},{"id":2060309,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63270,"kind":"person","name":"CONN GREGORY","position":1,"cik":"0001770008","reported_name":"CONN GREGORY","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-01-06T21:59:15.000Z","date":"2023-01-05","kind":"grant","acquired":true,"shares":137200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, representing a right to purchase a total of 137,200 shares of Common Stock, will become exercisable on January 5, 2024, with 25% vesting on that date and the remaining 75% vesting in equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date, until fully vested on January 5, 2027."}],"balance_after":137200,"derivative":{"exercise_price":11.61,"expiration_date":"2033-01-05","underlying":"Common Stock","underlying_shares":137200},"source":{"system":"sec-edgar","filing":"0001140361-23-000825","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036123000825/form4.xml","form_type":"4"}},{"id":2060307,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63271,"kind":"person","name":"BEDU-ADDO FRANK","position":1,"cik":"0001770756","reported_name":"BEDU-ADDO FRANK","relationship":{"director":true,"officer":true,"officer_title":"President/CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-01-06T21:59:10.000Z","date":"2023-01-05","kind":"grant","acquired":true,"shares":385300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, representing a right to purchase a total of 385,300 shares of Common Stock, will become exercisable on January 5, 2024, with 25% vesting on that date and the remaining 75% vesting in equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date, until fully vested on January 5, 2027."}],"balance_after":385300,"derivative":{"exercise_price":11.61,"expiration_date":"2033-01-05","underlying":"Common Stock","underlying_shares":385300},"source":{"system":"sec-edgar","filing":"0001140361-23-000824","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036123000824/form4.xml","form_type":"4"}},{"id":2060306,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":120880,"kind":"person","name":"WOOD LAUREN","position":1,"cik":"0001769757","reported_name":"WOOD LAUREN","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-01-06T21:59:06.000Z","date":"2023-01-05","kind":"grant","acquired":true,"shares":110800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, representing a right to purchase a total of 110,800 shares of Common Stock, will become exercisable on January 5, 2024, with 25% vesting on that date and the remaining 75% vesting in equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date, until fully vested on January 5, 2027."}],"balance_after":110800,"derivative":{"exercise_price":11.61,"expiration_date":"2033-01-05","underlying":"Common Stock","underlying_shares":110800},"source":{"system":"sec-edgar","filing":"0001140361-23-000823","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036123000823/form4.xml","form_type":"4"}},{"id":2060746,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63388,"kind":"person","name":"Brown Spencer D.","position":1,"cik":"0001930908","reported_name":"Brown Spencer D.","relationship":{"officer":true,"officer_title":"Senior VP, General Counsel"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-01-06T16:59:20.000Z","date":"2023-01-05","kind":"grant","acquired":true,"shares":20400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, representing a right to purchase a total of 20,400 shares of Common Stock, will become exercisable on January 5, 2024, with 25% vesting on that date and the remaining 75% vesting in equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date, until fully vested on January 5, 2027."}],"balance_after":20400,"derivative":{"exercise_price":11.61,"expiration_date":"2033-01-05","underlying":"Common Stock","underlying_shares":20400},"source":{"system":"sec-edgar","filing":"0001140361-23-000827","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1930908/000114036123000827/form4.xml","form_type":"4"}},{"id":2098171,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63271,"kind":"person","name":"BEDU-ADDO FRANK","position":1,"cik":"0001770756","reported_name":"BEDU-ADDO FRANK","relationship":{"director":true,"officer":true,"officer_title":"President/CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-02T21:47:14.000Z","date":"2022-12-02","kind":"exercise","acquired":false,"shares":219535,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was fully vested in accordance with its terms."}],"balance_after":0,"derivative":{"exercise_price":6.57,"expiration_date":"2022-12-03","underlying":"Common Stock","underlying_shares":219535},"source":{"system":"sec-edgar","filing":"0001140361-22-044259","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036122044259/form4.xml","form_type":"4"}},{"id":2098170,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63271,"kind":"person","name":"BEDU-ADDO FRANK","position":1,"cik":"0001770756","reported_name":"BEDU-ADDO FRANK","relationship":{"director":true,"officer":true,"officer_title":"President/CEO"}}],"security":"Common Stock","published_at":"2022-12-02T21:47:14.000Z","date":"2022-12-02","kind":"tax_withholding","acquired":false,"shares":175184,"price":9.78,"value":1713299.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On December 2, 2022, Dr. Bedu-Addo made a net exercise of 219,535 stock options, resulting in his acquisition of 44,351 common shares of the Issuer."}],"balance_after":690866,"source":{"system":"sec-edgar","filing":"0001140361-22-044259","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036122044259/form4.xml","form_type":"4"}},{"id":2098169,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63271,"kind":"person","name":"BEDU-ADDO FRANK","position":1,"cik":"0001770756","reported_name":"BEDU-ADDO FRANK","relationship":{"director":true,"officer":true,"officer_title":"President/CEO"}}],"security":"Common Stock","published_at":"2022-12-02T21:47:14.000Z","date":"2022-12-02","kind":"exercise","acquired":true,"shares":219535,"price":6.57,"value":1442344.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On December 2, 2022, Dr. Bedu-Addo made a net exercise of 219,535 stock options, resulting in his acquisition of 44,351 common shares of the Issuer."}],"balance_after":866050,"source":{"system":"sec-edgar","filing":"0001140361-22-044259","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036122044259/form4.xml","form_type":"4"}},{"id":2219339,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":41889,"kind":"person","name":"Glover Stephen C.","position":1,"cik":"0001304406","reported_name":"Glover Steve C","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-29T20:16:07.000Z","date":"2022-06-28","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date."}],"balance_after":9000,"derivative":{"exercise_price":3.9,"expiration_date":"2032-06-28","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001140361-22-024470","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036122024470/form4.xml","form_type":"4"}},{"id":2219409,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":38773,"kind":"person","name":"BRAWLEY OTIS W","position":1,"cik":"0001213029","reported_name":"BRAWLEY OTIS W","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-29T20:15:48.000Z","date":"2022-06-28","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date."}],"balance_after":9000,"derivative":{"exercise_price":3.9,"expiration_date":"2032-06-28","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001140361-22-024468","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036122024468/form4.xml","form_type":"4"}},{"id":2219338,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":89556,"kind":"person","name":"SYKES RICHARD","position":1,"cik":"0001372810","reported_name":"SYKES RICHARD","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-29T20:15:41.000Z","date":"2022-06-28","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date."}],"balance_after":9000,"derivative":{"exercise_price":3.9,"expiration_date":"2032-06-28","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001140361-22-024467","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036122024467/form4.xml","form_type":"4"}},{"id":2219372,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":35786,"kind":"person","name":"Ali-Jackson Kamil","position":1,"cik":"0001654337","reported_name":"Ali-Jackson Kamil","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-29T20:15:35.000Z","date":"2022-06-28","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date."}],"balance_after":9000,"derivative":{"exercise_price":3.9,"expiration_date":"2032-06-28","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001140361-22-024466","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654337/000114036122024466/form4.xml","form_type":"4"}},{"id":2219411,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63352,"kind":"person","name":"Iliev Ilian","position":1,"cik":"0001808804","reported_name":"Iliev Ilian","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-29T16:15:57.000Z","date":"2022-06-28","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date."}],"balance_after":9000,"derivative":{"exercise_price":3.9,"expiration_date":"2032-06-28","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001140361-22-024469","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808804/000114036122024469/form4.xml","form_type":"4"}},{"id":2219361,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-29T16:15:42.000Z","date":"2022-06-28","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date."}],"balance_after":9000,"derivative":{"exercise_price":3.9,"expiration_date":"2032-06-28","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001140361-22-024465","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492710/000114036122024465/form4.xml","form_type":"4"}},{"id":2245304,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63388,"kind":"person","name":"Brown Spencer D.","position":1,"cik":"0001930908","reported_name":"Brown Spencer D.","relationship":{"officer":true,"officer_title":"Senior VP, General Counsel"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-06-03T08:20:28.000Z","date":"2022-06-02","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted by the Issuer as an inducement material to the Reporting Person entering into employment with the Issuer in accordance with Nasdaq Rule 5635(c)(4) and the Issuer's 2019 Inducement Plan, as amended. This option, representing a right to purchase a total of 150,000 shares of Common Stock, will become exercisable on June 2, 2023, with 25% vesting on that date and the remaining 75% vesting in equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date."}],"balance_after":150000,"derivative":{"exercise_price":4.22,"expiration_date":"2032-06-02","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001140361-22-021673","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1930908/000114036122021673/form4.xml","form_type":"4"}},{"id":2430415,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63270,"kind":"person","name":"CONN GREGORY","position":1,"cik":"0001770008","reported_name":"CONN GREGORY","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-01-20T21:05:39.000Z","date":"2022-01-19","kind":"grant","acquired":true,"shares":112100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, representing a right to purchase a total of 112,100 shares of Common Stock, will become exercisable on January 19, 2023, with 25% vesting on that date and the remaining 75% vesting in equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date, until fully vested on January 19, 2026."}],"balance_after":112100,"derivative":{"exercise_price":6.28,"expiration_date":"2032-01-19","underlying":"Common Stock","underlying_shares":112100},"source":{"system":"sec-edgar","filing":"0001140361-22-002189","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036122002189/form4.xml","form_type":"4"}},{"id":2430414,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63271,"kind":"person","name":"BEDU-ADDO FRANK","position":1,"cik":"0001770756","reported_name":"BEDU-ADDO FRANK","relationship":{"director":true,"officer":true,"officer_title":"President/CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-20T21:05:37.000Z","date":"2022-01-19","kind":"grant","acquired":false,"shares":291500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, representing a right to purchase a total of 291,500 shares of Common Stock, will become exercisable on January 19, 2023, with 25% vesting on that date and the remaining vesting in equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date, until fully vested on January 19, 2026."}],"balance_after":291500,"derivative":{"exercise_price":6.28,"expiration_date":"2032-01-19","underlying":"Common Stock","underlying_shares":291500},"source":{"system":"sec-edgar","filing":"0001140361-22-002188","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036122002188/form4.xml","form_type":"4"}},{"id":2430413,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":120880,"kind":"person","name":"WOOD LAUREN","position":1,"cik":"0001769757","reported_name":"WOOD LAUREN","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-01-20T21:05:34.000Z","date":"2022-01-19","kind":"grant","acquired":true,"shares":88600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, representing a right to purchase a total of 88,600 shares of Common Stock, will become exercisable on January 19, 2023, with 25% vesting on that date and the remaining 75% vesting in equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date, until fully vested on January 19, 2026."}],"balance_after":88600,"derivative":{"exercise_price":6.28,"expiration_date":"2032-01-19","underlying":"Common Stock","underlying_shares":88600},"source":{"system":"sec-edgar","filing":"0001140361-22-002187","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036122002187/form4.xml","form_type":"4"}},{"id":2473539,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":38435,"kind":"person","name":"HILL MATTHEW C","position":1,"cik":"0001278675","reported_name":"HILL MATTHEW C","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-12-14T14:10:53.000Z","date":"2021-12-13","kind":"purchase","acquired":true,"shares":100,"price":9,"value":900.0,"ownership":{"direct":false,"nature":"Daughter"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares acquired on the open market."}],"balance_after":4075,"source":{"system":"sec-edgar","filing":"0001140361-21-041473","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036121041473/form4.xml","form_type":"4"}},{"id":2473538,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":38435,"kind":"person","name":"HILL MATTHEW C","position":1,"cik":"0001278675","reported_name":"HILL MATTHEW C","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-12-14T14:10:53.000Z","date":"2021-12-13","kind":"purchase","acquired":true,"shares":100,"price":9,"value":900.0,"ownership":{"direct":false,"nature":"Son"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares acquired on the open market."}],"balance_after":3975,"source":{"system":"sec-edgar","filing":"0001140361-21-041473","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036121041473/form4.xml","form_type":"4"}},{"id":2473537,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":38435,"kind":"person","name":"HILL MATTHEW C","position":1,"cik":"0001278675","reported_name":"HILL MATTHEW C","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-12-14T14:10:53.000Z","date":"2021-12-13","kind":"purchase","acquired":true,"shares":400,"price":8.9,"value":3560.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares acquired on the open market."}],"balance_after":3875,"source":{"system":"sec-edgar","filing":"0001140361-21-041473","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036121041473/form4.xml","form_type":"4"}},{"id":2473536,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":38435,"kind":"person","name":"HILL MATTHEW C","position":1,"cik":"0001278675","reported_name":"HILL MATTHEW C","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-12-14T14:10:53.000Z","date":"2021-12-13","kind":"purchase","acquired":true,"shares":2500,"price":9,"value":22500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares acquired on the open market."}],"balance_after":3475,"source":{"system":"sec-edgar","filing":"0001140361-21-041473","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036121041473/form4.xml","form_type":"4"}},{"id":2538135,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":38435,"kind":"person","name":"HILL MATTHEW C","position":1,"cik":"0001278675","reported_name":"HILL MATTHEW C","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-20T20:31:00.000Z","date":"2021-10-19","kind":"grant","acquired":true,"shares":202800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted by the Issuer as an inducement material to the Reporting Person entering into employment with the Issuer in accordance with Nasdaq Rule 5635(c)(4) and the Issuer's 2019 Inducement Plan, as amended.  The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on October 19, 2022, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":202800,"derivative":{"exercise_price":12.03,"expiration_date":"2031-10-19","underlying":"Common Stock","underlying_shares":202800},"source":{"system":"sec-edgar","filing":"0001140361-21-034999","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036121034999/form4.xml","form_type":"4"}},{"id":2660872,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":76506,"kind":"person","name":"Bloomquist DeLyle W","position":1,"cik":"0001315488","reported_name":"Bloomquist DeLyle W","relationship":{"other":true,"other_text":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-21T20:30:48.000Z","date":"2021-06-16","kind":"exercise","acquired":false,"shares":2970,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One third of the shares underlying the option shall vest upon each of the first, second, and third anniversaries of the date of grant, such that the option will be fully vested on June 28, 2022, subject in all respects to the option agreement governing the stock option grant."}],"balance_after":6030,"derivative":{"exercise_price":5.99,"expiration_date":"2029-06-28","underlying":"Common Stock","underlying_shares":2970},"source":{"system":"sec-edgar","filing":"0001140361-21-021720","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036121021720/form4.xml","form_type":"4"}},{"id":2660871,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":76506,"kind":"person","name":"Bloomquist DeLyle W","position":1,"cik":"0001315488","reported_name":"Bloomquist DeLyle W","relationship":{"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2021-06-21T20:30:48.000Z","date":"2021-06-16","kind":"purchase","acquired":true,"shares":10000,"price":9.8778,"value":98778.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents shares of Common Stock of the Issuer that Mr. Bloomquist purchased in the open market. The price reported in Column 4 is a weighted average price.  The shares were purchased in multiple transactions at prices ranging from $9.85 to $9.90, inclusive."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"The shares reported on this Form 4 are subject to a lock-up agreement between Mr. Bloomquist and Cantor Fitzgerald & Co. in connection with a public offering of common shares by the Issuer which closed on June 17, 2021."}],"balance_after":193888,"source":{"system":"sec-edgar","filing":"0001140361-21-021720","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036121021720/form4.xml","form_type":"4"}},{"id":2660870,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":76506,"kind":"person","name":"Bloomquist DeLyle W","position":1,"cik":"0001315488","reported_name":"Bloomquist DeLyle W","relationship":{"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2021-06-21T20:30:48.000Z","date":"2021-06-16","kind":"exercise","acquired":true,"shares":2970,"price":5.99,"value":17790.3,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"The shares reported on this Form 4 are subject to a lock-up agreement between Mr. Bloomquist and Cantor Fitzgerald & Co. in connection with a public offering of common shares by the Issuer which closed on June 17, 2021."}],"balance_after":183888,"source":{"system":"sec-edgar","filing":"0001140361-21-021720","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036121021720/form4.xml","form_type":"4"}},{"id":2663667,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63271,"kind":"person","name":"BEDU-ADDO FRANK","position":1,"cik":"0001770756","reported_name":"BEDU-ADDO FRANK","relationship":{"director":true,"officer":true,"officer_title":"President/CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-17T23:26:07.000Z","date":"2021-06-15","kind":"exercise","acquired":false,"shares":53174,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Option is fully vested in accordance with its terms."}],"balance_after":0,"derivative":{"exercise_price":6.57,"expiration_date":"2021-07-27","underlying":"Common Stock","underlying_shares":53174},"source":{"system":"sec-edgar","filing":"0001140361-21-021503","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036121021503/form4.xml","form_type":"4"}},{"id":2663666,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63271,"kind":"person","name":"BEDU-ADDO FRANK","position":1,"cik":"0001770756","reported_name":"BEDU-ADDO FRANK","relationship":{"director":true,"officer":true,"officer_title":"President/CEO"}}],"security":"Common Stock","published_at":"2021-06-17T23:26:07.000Z","date":"2021-06-15","kind":"tax_withholding","acquired":false,"shares":27166,"price":12.86,"value":349354.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 15, 2021, Mr. Bedu-Addo made a net exercise of 53,174 stock options, resulting in his acquisition of 26,008 common shares of the Issuer. The transaction was made pursuant to an exception to a lock-up agreement between Mr. Bedu Addo and Cantor Fitzgerald & Co.in connection with a public offering of common shares by the Issuer which closed on June 17, 2021."}],"balance_after":646515,"source":{"system":"sec-edgar","filing":"0001140361-21-021503","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036121021503/form4.xml","form_type":"4"}},{"id":2663665,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63271,"kind":"person","name":"BEDU-ADDO FRANK","position":1,"cik":"0001770756","reported_name":"BEDU-ADDO FRANK","relationship":{"director":true,"officer":true,"officer_title":"President/CEO"}}],"security":"Common Stock","published_at":"2021-06-17T23:26:07.000Z","date":"2021-06-15","kind":"exercise","acquired":true,"shares":53174,"price":6.57,"value":349353.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 15, 2021, Mr. Bedu-Addo made a net exercise of 53,174 stock options, resulting in his acquisition of 26,008 common shares of the Issuer. The transaction was made pursuant to an exception to a lock-up agreement between Mr. Bedu Addo and Cantor Fitzgerald & Co.in connection with a public offering of common shares by the Issuer which closed on June 17, 2021."}],"balance_after":673681,"source":{"system":"sec-edgar","filing":"0001140361-21-021503","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036121021503/form4.xml","form_type":"4"}},{"id":2663664,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":38773,"kind":"person","name":"BRAWLEY OTIS W","position":1,"cik":"0001213029","reported_name":"BRAWLEY OTIS W","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-17T23:20:51.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in full and become fully exercisable on June 17, 2022."}],"balance_after":9000,"derivative":{"exercise_price":9.95,"expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001140361-21-021501","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036121021501/form4.xml","form_type":"4"}},{"id":2663669,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":41889,"kind":"person","name":"Glover Stephen C.","position":1,"cik":"0001304406","reported_name":"Glover Steve C","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-17T23:15:26.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Option will vest in full and become fully exercisable on June 17, 2022."}],"balance_after":9000,"derivative":{"exercise_price":9.95,"expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001140361-21-021499","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036121021499/form4.xml","form_type":"4"}},{"id":2663668,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":41889,"kind":"person","name":"Glover Stephen C.","position":1,"cik":"0001304406","reported_name":"Glover Steve C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-06-17T23:15:26.000Z","date":"2021-06-15","kind":"purchase","acquired":true,"shares":5882,"price":8.5,"value":49997.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock purchased by the Reporting Person at the public offering price in connection with the Issuer's firm commitment underwritten public offering of common stock, which closed on June 17, 2021, and such shares of common stock are subject to a lock up agreement between the Reporting Person and Cantor Fitzgerald & Co., pursuant to which the shares cannot be sold for 90 days following June 15, 2021."}],"balance_after":63790,"source":{"system":"sec-edgar","filing":"0001140361-21-021499","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036121021499/form4.xml","form_type":"4"}},{"id":2663803,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":35786,"kind":"person","name":"Ali-Jackson Kamil","position":1,"cik":"0001654337","reported_name":"Ali-Jackson Kamil","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-17T23:09:59.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Option will vest in full and become fully exercisable on June 17, 2022."}],"balance_after":9000,"derivative":{"exercise_price":9.95,"expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001140361-21-021497","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654337/000114036121021497/form4.xml","form_type":"4"}},{"id":2663802,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":35786,"kind":"person","name":"Ali-Jackson Kamil","position":1,"cik":"0001654337","reported_name":"Ali-Jackson Kamil","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-06-17T23:09:59.000Z","date":"2021-06-15","kind":"purchase","acquired":true,"shares":11764,"price":8.5,"value":99994.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock purchased by the Reporting Person at the public offering price in connection with the Issuer's firm commitment underwritten public offering of common stock, which closed on June 17, 2021, and such shares of common stock are subject to a lock up agreement between the Reporting Person and Cantor Fitzgerald & Co., pursuant to which the shares cannot be sold for 90 days following June 15, 2021."}],"balance_after":11764,"source":{"system":"sec-edgar","filing":"0001140361-21-021497","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654337/000114036121021497/form4.xml","form_type":"4"}},{"id":2663663,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":89556,"kind":"person","name":"SYKES RICHARD","position":1,"cik":"0001372810","reported_name":"SYKES RICHARD","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-17T23:03:49.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in full and become fully exercisable on June 17, 2022."}],"balance_after":9000,"derivative":{"exercise_price":9.95,"expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001140361-21-021495","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036121021495/form4.xml","form_type":"4"}},{"id":2663662,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":121460,"kind":"person","name":"VAN VOORHEES SETH","position":1,"cik":"0001284934","reported_name":"VAN VOORHEES SETH","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-06-17T22:52:14.000Z","date":"2021-06-15","kind":"purchase","acquired":true,"shares":17647,"price":8.5,"value":149999.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock purchased by the Reporting Person at the public offering price in connection with the Issuer's firm commitment underwritten public offering of common stock, which closed on June 17, 2021, and such shares of common stock are subject to a lock up agreement between the Reporting Person and Cantor Fitzgerald & Co., pursuant to which the shares cannot be sold for 90 days following June 15, 2021."}],"balance_after":17647,"source":{"system":"sec-edgar","filing":"0001140361-21-021491","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036121021491/form4.xml","form_type":"4"}},{"id":2664064,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63352,"kind":"person","name":"Iliev Ilian","position":1,"cik":"0001808804","reported_name":"Iliev Ilian","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-17T18:58:23.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest in full and become fully exercisable on June 17, 2022."}],"balance_after":9000,"derivative":{"exercise_price":9.95,"expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001140361-21-021493","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808804/000114036121021493/form4.xml","form_type":"4"}},{"id":2663713,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-17T18:45:33.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Option will vest in full and become fully exercisable on June 17, 2022."}],"balance_after":9000,"derivative":{"exercise_price":9.95,"expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001140361-21-021489","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492710/000114036121021489/form4.xml","form_type":"4"}},{"id":2663712,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-06-17T18:45:33.000Z","date":"2021-06-15","kind":"purchase","acquired":true,"shares":5882,"price":8.5,"value":49997.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock purchased by the Reporting Person at the public offering price in connection with the Issuer's firm commitment underwritten public offering of common stock, which closed on June 17, 2021, and such shares of common stock are subject to a lock up agreement between the Reporting Person and Cantor Fitzgerald & Co., pursuant to which the shares cannot be sold for 90 days following June 15, 2021."}],"balance_after":46153,"source":{"system":"sec-edgar","filing":"0001140361-21-021489","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492710/000114036121021489/form4.xml","form_type":"4"}},{"id":2915432,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":121460,"kind":"person","name":"VAN VOORHEES SETH","position":1,"cik":"0001284934","reported_name":"VAN VOORHEES SETH","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-06T21:06:01.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":202800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted by the Issuer as an inducement material to the Reporting Person entering into employment with the Issuer in accordance with Nasdaq Rule 5635(c)(4) and the Issuer's 2019 Inducement Plan, as amended.  The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on January 1, 2022, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":202800,"derivative":{"exercise_price":2.28,"expiration_date":"2031-01-04","underlying":"Common Stock","underlying_shares":202800},"source":{"system":"sec-edgar","filing":"0001140361-21-000334","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036121000334/form4.xml","form_type":"4"}},{"id":2951677,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63270,"kind":"person","name":"CONN GREGORY","position":1,"cik":"0001770008","reported_name":"CONN GREGORY","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-09T21:20:28.000Z","date":"2020-12-08","kind":"grant","acquired":true,"shares":122400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on December 8, 2020, subject to stockholder approval of the Issuer's Second Amended and Restated 2014 Equity Incentive Plan under Nasdaq Marketplace Rule 5635(c). The option is not exercisable until stockholder approval has been obtained. Contingent upon stockholder approval, one-quarter of the shares subject to the option shall vest on December 8, 2021, and the remainder shall vest in equal monthly installments thereafter until fully vested on December 8, 2024. In the event stockholder approval is not obtained pursuant to the terms of grant, then the Reporting Person shall surrender the option to the Company for cancellation."}],"balance_after":122400,"derivative":{"exercise_price":2.43,"expiration_date":"2030-12-08","underlying":"Common Stock","underlying_shares":122400},"source":{"system":"sec-edgar","filing":"0001140361-20-027874","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036120027874/form4.xml","form_type":"4"}},{"id":2951676,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":120880,"kind":"person","name":"WOOD LAUREN","position":1,"cik":"0001769757","reported_name":"WOOD LAUREN","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-09T21:17:04.000Z","date":"2020-12-08","kind":"grant","acquired":true,"shares":210500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on December 8, 2020, subject to stockholder approval of the Issuer's Second Amended and Restated 2014 Equity Incentive Plan under Nasdaq Marketplace Rule 5635(c). The option is not exercisable until stockholder approval has been obtained. Contingent upon stockholder approval, one-quarter of the shares subject to the option shall vest on December 8, 2021, and the remainder shall vest in equal monthly installments thereafter until fully vested on December 8, 2024. In the event stockholder approval is not obtained pursuant to the terms of grant, then the Reporting Person shall surrender the option to the Company for cancellation."}],"balance_after":210500,"derivative":{"exercise_price":2.43,"expiration_date":"2030-12-08","underlying":"Common Stock","underlying_shares":210500},"source":{"system":"sec-edgar","filing":"0001140361-20-027869","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036120027869/form4.xml","form_type":"4"}},{"id":2951675,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63271,"kind":"person","name":"BEDU-ADDO FRANK","position":1,"cik":"0001770756","reported_name":"BEDU-ADDO FRANK","relationship":{"director":true,"officer":true,"officer_title":"President/CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-09T21:10:08.000Z","date":"2020-12-08","kind":"grant","acquired":true,"shares":707800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on December 8, 2020, subject to stockholder approval of the Issuer's Second Amended and Restated 2014 Equity Incentive Plan under Nasdaq Marketplace Rule 5635(c). The option is not exercisable until stockholder approval has been obtained. Contingent upon stockholder approval, one-quarter of the shares subject to the option shall vest on December 8, 2021, and the remainder shall vest in equal monthly installments thereafter until fully vested on December 8, 2024. In the event stockholder approval is not obtained pursuant to the terms of grant, then the Reporting Person shall surrender the option to the Company for cancellation."}],"balance_after":707800,"derivative":{"exercise_price":2.43,"expiration_date":"2030-12-08","underlying":"Common Stock","underlying_shares":707800},"source":{"system":"sec-edgar","filing":"0001140361-20-027860","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036120027860/form4.xml","form_type":"4"}},{"id":2952036,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":144794,"kind":"person","name":"King Michael N.","position":1,"cik":"0001816304","reported_name":"King Michael N.","relationship":{"officer":true,"officer_title":"Interim CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-09T16:13:11.000Z","date":"2020-12-08","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and immediately exercisable as of the date of grant."}],"balance_after":50000,"derivative":{"exercise_price":2.43,"expiration_date":"2030-12-08","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001140361-20-027866","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816304/000114036120027866/form4.xml","form_type":"4"}},{"id":2989678,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":38773,"kind":"person","name":"BRAWLEY OTIS W","position":1,"cik":"0001213029","reported_name":"BRAWLEY OTIS W","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-06T23:19:08.000Z","date":"2020-11-03","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third (1/3) of the shares underlying the option shall vest upon each of the first, second and third anniversaries of the date of grant, such that the option will be fully vested on November 3, 2023."}],"balance_after":9000,"derivative":{"exercise_price":2.09,"expiration_date":"2030-11-03","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001140361-20-024925","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036120024925/form4.xml","form_type":"4"}},{"id":3099734,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":41889,"kind":"person","name":"Glover Stephen C.","position":1,"cik":"0001304406","reported_name":"Glover Steve C","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-25T22:57:22.000Z","date":"2020-06-23","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One third of the shares underlying the option shall vest upon each of the first, second, and third anniversaries of the date of grant, such that the option will be fully vested on June 23, 2023."}],"balance_after":9000,"derivative":{"exercise_price":1.45,"expiration_date":"2030-06-23","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001140361-20-014781","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036120014781/form4.xml","form_type":"4"}},{"id":3099733,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":89556,"kind":"person","name":"SYKES RICHARD","position":1,"cik":"0001372810","reported_name":"SYKES RICHARD","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-25T22:43:07.000Z","date":"2020-06-23","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One third of the shares underlying the option shall vest upon each of the first, second, and third anniversaries of the date of grant, such that the option will be fully vested on June 23, 2023."}],"balance_after":9000,"derivative":{"exercise_price":1.45,"expiration_date":"2030-06-23","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001140361-20-014772","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036120014772/form4.xml","form_type":"4"}},{"id":3099793,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":35786,"kind":"person","name":"Ali-Jackson Kamil","position":1,"cik":"0001654337","reported_name":"Ali-Jackson Kamil","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-25T22:38:55.000Z","date":"2020-06-23","kind":"grant","acquired":true,"shares":3033,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One third of the shares underlying the option shall vest upon each of the first, second, and third anniversaries of the date of grant, such that the option will be fully vested on June 23, 2023."}],"balance_after":3033,"derivative":{"exercise_price":1.45,"expiration_date":"2030-06-23","underlying":"Common Stock","underlying_shares":3033},"source":{"system":"sec-edgar","filing":"0001140361-20-014769","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654337/000114036120014769/form4.xml","form_type":"4"}},{"id":3099732,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":120880,"kind":"person","name":"WOOD LAUREN","position":1,"cik":"0001769757","reported_name":"WOOD LAUREN","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-06-25T22:35:11.000Z","date":"2020-06-23","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, representing a right to purchase a total of 35,000 shares of Common Stock, will become exercisable on June 23, 2021, with 25% vesting on that date and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date."}],"balance_after":35000,"derivative":{"exercise_price":1.45,"expiration_date":"2030-06-23","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001140361-20-014767","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036120014767/form4.xml","form_type":"4"}},{"id":3099731,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":76506,"kind":"person","name":"Bloomquist DeLyle W","position":1,"cik":"0001315488","reported_name":"Bloomquist DeLyle W","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-25T22:33:38.000Z","date":"2020-06-23","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One third of the shares underlying the option shall vest upon each of the first, second, and third anniversaries of the date of grant, such that the option will be fully vested on June 23, 2023."}],"balance_after":9000,"derivative":{"exercise_price":1.45,"expiration_date":"2030-06-23","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001140361-20-014765","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036120014765/form4.xml","form_type":"4"}},{"id":3099730,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63270,"kind":"person","name":"CONN GREGORY","position":1,"cik":"0001770008","reported_name":"CONN GREGORY","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-06-25T22:29:36.000Z","date":"2020-06-23","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, representing a right to purchase a total of 35,000 shares of Common Stock, will become exercisable on June 23, 2021, with 25% vesting on that date and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date."}],"balance_after":35000,"derivative":{"exercise_price":1.45,"expiration_date":"2030-06-23","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001140361-20-014762","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036120014762/form4.xml","form_type":"4"}},{"id":3099728,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63271,"kind":"person","name":"BEDU-ADDO FRANK","position":1,"cik":"0001770756","reported_name":"BEDU-ADDO FRANK","relationship":{"director":true,"officer":true,"officer_title":"President/CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-06-25T22:24:38.000Z","date":"2020-06-23","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, representing a right to purchase a total of 125,000 shares of Common Stock, will become exercisable on June 23, 2021, with 25% vesting on that date and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date."}],"balance_after":125000,"derivative":{"exercise_price":1.45,"expiration_date":"2030-06-23","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001140361-20-014759","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036120014759/form4.xml","form_type":"4"}},{"id":3099740,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63293,"kind":"person","name":"Freitag Gregory Gene","position":1,"cik":"0001492710","reported_name":"Freitag Gregory Gene","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-25T18:43:28.000Z","date":"2020-06-23","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One third of the shares underlying the option shall vest upon each of the first, second, and third anniversaries of the date of grant, such that the option will be fully vested on June 23, 2023."}],"balance_after":9000,"derivative":{"exercise_price":1.45,"expiration_date":"2030-06-23","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001140361-20-014773","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492710/000114036120014773/form4.xml","form_type":"4"}},{"id":3099993,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63352,"kind":"person","name":"Iliev Ilian","position":1,"cik":"0001808804","reported_name":"Iliev Ilian","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-25T18:32:33.000Z","date":"2020-06-23","kind":"grant","acquired":true,"shares":1874,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One third of the shares underlying the option shall vest upon each of the first, second, and third anniversaries of the date of grant, such that the option will be fully vested on June 23, 2023."}],"balance_after":1874,"derivative":{"exercise_price":1.45,"expiration_date":"2030-06-23","underlying":"Common Stock","underlying_shares":1874},"source":{"system":"sec-edgar","filing":"0001140361-20-014764","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808804/000114036120014764/form4.xml","form_type":"4"}},{"id":3179096,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":63352,"kind":"person","name":"Iliev Ilian","position":1,"cik":"0001808804","reported_name":"Iliev Ilian","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-09T16:49:44.000Z","date":"2020-04-08","kind":"grant","acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third (1/3) of the shares underlying the option shall vest upon each of the first, second and third anniversaries of the date of grant, such that the option will be fully vested on April 8, 2023."}],"balance_after":4500,"derivative":{"exercise_price":0.72,"expiration_date":"2030-04-08","underlying":"Common Stock","underlying_shares":4500},"source":{"system":"sec-edgar","filing":"0001140361-20-008509","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808804/000114036120008509/form4.xml","form_type":"4"}},{"id":3253001,"issuer":{"id":7939,"kind":"organization","name":"PDS Biotechnology Corp","symbol":"PDSB"},"owners":[{"id":35786,"kind":"person","name":"Ali-Jackson Kamil","position":1,"cik":"0001654337","reported_name":"Ali-Jackson Kamil","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-24T21:30:53.000Z","date":"2020-02-21","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third (1/3) of the shares underlying the option shall vest upon each of the first, second and third anniversaries of the date of grant, such that the option will be fully vested on February 21, 2023."}],"balance_after":9000,"derivative":{"exercise_price":1.31,"expiration_date":"2030-02-21","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001140361-20-003908","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654337/000114036120003908/form4.xml","form_type":"4"}}],"next_cursor":"2020-02-24T21:30:53.000000Z,3253001"}